Surgery for Pulmonary Hypertension: Your Guide | myPHteam

Connect with others who understand.

sign up Log in
Resources
About myPHteam
Powered By

Surgery for Pulmonary Hypertension: Your Guide

Medically reviewed by Steven C. Pugliese, M.D.
Written by Aminah Wali, Ph.D.
Updated on August 12, 2021

Pulmonary hypertension (PH) is a medical condition in which high blood pressure affects the arteries of the lungs and the right ventricle of the heart. To reduce the chance of right heart failure and death, PH must be treated promptly. While there are medications available to treat PH, in some cases surgery is required. There are several surgical options that may be recommended depending on the type of PH and the stage of heart disease.

Atrial Septostomy

For one form of PH known as pulmonary arterial hypertension (PAH), a surgical procedure called atrial septostomy may be recommended in severe cases. In this procedure, a surgeon uses a catheter to make a hole in the wall between the left and right sides of the heart. Blood can pass through the hole from the right side of the heart to the left side, thereby relieving pressure on the right side of the heart.

When Do Doctors Recommend Atrial Septostomy?

Idiopathic PAH, which occurs due to an unknown cause, may not respond well to other treatments and can progress to right heart failure. The atrial septostomy procedure may be recommended for people in such severe cases. The procedure may also be an option for those who cannot receive a lung transplant.

Outcomes of Atrial Septostomy

Because the procedure is only performed rarely in severe cases, the impact of atrial septostomy on survival is not well understood. It is not a cure, but rather is used to treat symptoms of PAH. There are risks to the procedure, so it should be performed only when the benefits outweigh the risks.

Pulmonary Endarterectomy

Pulmonary endarterectomy (PEA), also called pulmonary thromboendarterectomy, is a surgery used to treat a form of PH called chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is caused by large blood clots in the pulmonary arteries of the lungs, often the result of a pulmonary embolism.

PEA is used to remove those blood clots and restore blood flow. During the procedure, a heart-lung machine (or cardiopulmonary bypass machine) takes over the role of the heart and lungs to keep a person alive while the heart is stopped. The surgeon then opens the pulmonary arteries and removes the blood clots that block the arteries.

Which Conditions Respond Best To Pulmonary Endarterectomy?

PEA is the primary treatment suggested to treat people with CTEPH who are eligible for surgery, although the procedure cannot be performed in all cases. The location of the blockage and certain high-risk factors will determine if a person diagnosed with CTEPH can undergo surgery.

Outcomes of Pulmonary Endarterectomy

PEA is a major heart surgery and comes with significant risks, including the risk of death. While PEA is generally successful, about 4 percent of people won’t survive the surgery. For some people, PEA has the potential to cure those diagnosed with CTEPH and eliminate the disease. Those who have PEA usually have to take Coumadin (warfarin), a blood thinner, for the remainder of their lives to prevent further blockage.

Balloon Pulmonary Angioplasty

Balloon pulmonary angioplasty (BPA) is a minimally invasive procedure used to treat pulmonary hypertension, particularly CTEPH. BPA relieves blockages by using a balloon to widen the arteries and restore blood flow to the lungs.

When Do Doctors Prescribe Balloon Pulmonary Angioplasty?

BPA is most likely to be recommended to people with CTEPH who are not eligible to receive pulmonary endarterectomy surgery.

Outcomes of Balloon Pulmonary Angioplasty

BPA can improve symptoms in people with CTEPH. However, because it is a newer procedure, the effect on survival is still not well understood. Additional research is needed to track the long-term impact of undergoing BPA.

Lung Transplantation

A lung transplant is another surgical treatment option for PH. This procedure involves replacing either one or both lungs with those of an organ donor. The donor should be a genetic match to the person receiving treatment, which can make it difficult to obtain a lung transplant.

When Is Lung Transplantation Most Successful?

Medications such as intravenous prostacyclins (like epoprostenol and treprostinil), phosphodiesterase inhibitors (like sildenafil and tadalafil), and endothelin receptor antagonists (like ambrisentan, bosentan, and macitentan) have greatly improved outcomes for people with PH — without the need for surgical intervention. However, many people with PH do not respond well to medications and may still be candidates for a lung transplant. The procedure may also be used for people with lung diseases such as chronic obstructive pulmonary disease (COPD) or pulmonary fibrosis who also have severe PH.

Outcomes of Lung Transplantation

Lung transplantation has the potential to improve survival and quality of life for people being treated for PH. As with any major surgery, there are risks such as bleeding and infection associated with a lung transplant. People who have received a lung transplant must take immunosuppressive drugs for the rest of their lives to keep their body from rejecting the donor lung. They must also attend regular follow-up appointments after the procedure to monitor any symptoms of disease or organ rejection.

Talk With Others Who Understand

On myPHteam, the social network for people with pulmonary hypertension and their loved ones, more than 37,000 members come together to ask questions, give advice, and share their stories with others who understand life with pulmonary hypertension.

Have you or a loved one had surgery for pulmonary hypertension? Share your experience in the comments below, or start a conversation by posting on your Activities page.

Updated on August 12, 2021
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest articles about pulmonary hypertension sent to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Steven C. Pugliese, M.D. is affiliated with the Hospital of the University of Pennsylvania in Philadelphia, serving as the director of the pulmonary embolism response team, co-director of the comprehensive pulmonary embolism program, and an assistant professor of clinical medicine. Review provided by VeriMed Healthcare Network. Learn more about him here
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here

Related Articles

Pulmonary arterial hypertension (PAH) is a serious condition that causes high blood pressure in t...

Targeting the Molecular Pathways That Cause PAH: What We Know

Pulmonary arterial hypertension (PAH) is a serious condition that causes high blood pressure in t...
For people who’ve felt the weight of fatigue due to pulmonary arterial hypertension (PAH), the pr...

New Pulmonary Arterial Hypertension Medications: 4 Advances in Treatment

For people who’ve felt the weight of fatigue due to pulmonary arterial hypertension (PAH), the pr...
Lisinopril is a medication that helps control high blood pressure. While lisinopril doesn’t cause...

Lisinopril and Weight Gain: Is There a Connection?

Lisinopril is a medication that helps control high blood pressure. While lisinopril doesn’t cause...
Doctors recommend pulmonary hypertension (PH) treatments based on several different factors, incl...

Treatments for Pulmonary Hypertension

Doctors recommend pulmonary hypertension (PH) treatments based on several different factors, incl...
Pulmonary arterial hypertension (PAH) can be mild, moderate, or severe, and the treatment your do...

3 Ways PAH Severity Impacts Treatment

Pulmonary arterial hypertension (PAH) can be mild, moderate, or severe, and the treatment your do...
Treating PAH with two or more therapies, known as combination therapy, is an effective way to man...

Finding the Best PAH Treatment: What Is Combination Therapy?

Treating PAH with two or more therapies, known as combination therapy, is an effective way to man...

Recent Articles

Pulmonary hypertension (PH) refers to high blood pressure in the blood vessels that travel betwee...

Pulmonary Venous Hypertension vs. Pulmonary Arterial Hypertension: What’s the Difference?

Pulmonary hypertension (PH) refers to high blood pressure in the blood vessels that travel betwee...
Supplements can offer a great way to boost your body’s amino acid levels — but with some, it’s po...

Can High Doses of NAC Cause Pulmonary Arterial Hypertension?

Supplements can offer a great way to boost your body’s amino acid levels — but with some, it’s po...
Welcome to myPHteam — the place to connect with others living with pulmonary hypertension (PH). ...

Getting Started on myPHteam (VIDEO)

Welcome to myPHteam — the place to connect with others living with pulmonary hypertension (PH). ...
You’ve recently gone to your doctor after experiencing shortness of breath when you exercise. The...

Borderline Pulmonary Hypertension: 6 Things To Know

You’ve recently gone to your doctor after experiencing shortness of breath when you exercise. The...
Pulmonary hypertension (PH) is often linked with several other conditions, one of which is Down s...

Pulmonary Hypertension and Down Syndrome: Is There a Connection?

Pulmonary hypertension (PH) is often linked with several other conditions, one of which is Down s...
Have you ever had a dry, tickly sensation in your throat that makes you cough and won’t go away? ...

Which Blood Pressure Medications Can Cause Coughing?

Have you ever had a dry, tickly sensation in your throat that makes you cough and won’t go away? ...
myPHteam My pulmonary hypertension Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close